Company
United StatesPierre Fabre Pharmaceuticals, Inc., Parsippany, NJ – FDA Inspections
Inspection records and compliance data for Pierre Fabre Pharmaceuticals, Inc. in Parsippany, New Jersey. 3 FDA inspections on record, 1 Form 483, last inspected November 01, 2024.
Company Profile
This profile covers Pierre Fabre Pharmaceuticals, Inc. based in Parsippany, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 3
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 0
First inspected December 30, 2015. Last inspected November 1, 2024.
Most cited issue areas
- Late submission of 15-day report3 inspections
- Incomplete initial reporter information on ICSR2 inspections
- Failure to develop written procedures1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 1, 2024 | VAI | Human Drugs · Postmarketing Surveillance and Epidemiology: Human Drugs | 1253273 |
| July 27, 2022 | VAI | Human Drugs · Bioresearch Monitoring | 1175515 |
| December 30, 2015 | VAI | Human Drugs · Bioresearch Monitoring | 956345 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Pierre Fabre Pharmaceuticals, Inc.
FEI Number
3013144400
Address
8 Campus Dr Ste 2, Parsippany, New Jersey 07054, United States
Country
United States
ID: ee0282e8-44f7-43c1-b3d5-fdc0c75129dc